Literature DB >> 8254047

Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.

W März1, M W Baumstark, H Scharnagl, V Ruzicka, S Buxbaum, J Herwig, T Pohl, A Russ, L Schaaf, A Berg.   

Abstract

The interaction of LDL and LDL subfractions from a patient homozygous for familial defective apoB-100 (FDB) has been studied. His LDL cholesterol ranged from 2.65 to 3.34 g/liter. In cultured fibroblasts, binding, internalization, and degradation of the patient's LDL was diminished, but not completely abolished. The patient's apolipoprotein E concentration was low, and the amount of apolipoprotein E associated with LDL was not elevated over normal. LDL were separated into six subfractions: LDL-1 (1.019-1.031 kg/liter), LDL-2 (1.031-1.034 kg/liter), LDL-3 (1.034-1.037 kg/liter), LDL-4 (1.037-1.040 kg/liter), LDL-5 (1.040-1.044 kg/liter), and LDL-6 (> 1.044 kg/liter). LDL-5 and LDL-6 selectively accumulated in the patient's plasma. Concentrations of LDL-1 to 3 were normal. The LDL receptor-mediated uptake of LDL-1 and LDL-2 could not be distinguished from normal LDL. LDL-3 and LDL-4 displayed reduced uptake; LDL-5 and LDL-6 were completely defective in binding. When apolipoprotein E-containing particles were removed by immunoabsorption before preparing subfractions, LDL-3 and LDL-4, but not LDL-1 and LDL-2, retained some receptor binding activity. We conclude that in FDB, LDL-1 and LDL-2 contain sufficient apolipoprotein E to warrant normal cellular uptake. In LDL-3 and LDL-4, the defective apoB-100 itself displays some receptor binding; LDL-5 and LDL-6 are inable to interact with LDL receptors and accumulate in plasma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254047      PMCID: PMC288496          DOI: 10.1172/JCI116915

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Familial defective apolipoprotein B-100: mild hypercholesterolaemia without atherosclerosis in a homozygous patient.

Authors:  W März; C Ruzicka; T Pohl; K H Usadel; W Gross
Journal:  Lancet       Date:  1992-11-28       Impact factor: 79.321

2.  Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24.

Authors:  A P Wojciechowski; M Farrall; P Cullen; T M Wilson; J D Bayliss; B Farren; B A Griffin; M J Caslake; C J Packard; J Shepherd
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

3.  Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with MspI.

Authors:  P S Hansen; N Rüdiger; A Tybjaerg-Hansen; O Faergeman; N Gregersen
Journal:  J Lipid Res       Date:  1991-07       Impact factor: 5.922

4.  Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.

Authors:  V M Maher; J J Gallagher; G R Thompson; N B Myant
Journal:  Atherosclerosis       Date:  1991-11       Impact factor: 5.162

5.  Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.

Authors:  N B Myant; J J Gallagher; B L Knight; S N McCarthy; J Frostegård; J Nilsson; A Hamsten; P Talmud; S E Humphries
Journal:  Arterioscler Thromb       Date:  1991 May-Jun

6.  Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

Authors:  G Schuler; R Hambrecht; G Schlierf; J Niebauer; K Hauer; J Neumann; E Hoberg; A Drinkmann; F Bacher; M Grunze
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

7.  Determination of lipoprotein(a): evaluation of three methods.

Authors:  W März; R Siekmeier; W Gross; G M Kostner
Journal:  Eur J Clin Chem Clin Biochem       Date:  1993-05

8.  Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor.

Authors:  F Nigon; P Lesnik; M Rouis; M J Chapman
Journal:  J Lipid Res       Date:  1991-11       Impact factor: 5.922

9.  Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19.

Authors:  P M Nishina; J P Johnson; J K Naggert; R M Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

10.  Apolipoprotein B(Arg3500----Gln) allele specific polymerase chain reaction: large-scale screening of pooled blood samples.

Authors:  V Ruzicka; W März; A Russ; W Gross
Journal:  J Lipid Res       Date:  1992-10       Impact factor: 5.922

View more
  6 in total

Review 1.  Statins in homozygous familial hypercholesterolemia.

Authors:  A D Marais; D J Blom; J C Firth
Journal:  Curr Atheroscler Rep       Date:  2002-01       Impact factor: 5.113

2.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

Review 3.  [Congenital disorders of lipoprotein metabolism].

Authors:  W März; T B Grammer; G Delgado; M E Kleber
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

Review 4.  Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs.

Authors:  Gamaleldin I Harisa; Fars K Alanazi
Journal:  Saudi Pharm J       Date:  2013-12-22       Impact factor: 4.330

5.  Computational lipidology: predicting lipoprotein density profiles in human blood plasma.

Authors:  Katrin Hübner; Thomas Schwager; Karl Winkler; Jens-Georg Reich; Hermann-Georg Holzhütter
Journal:  PLoS Comput Biol       Date:  2008-05-23       Impact factor: 4.475

6.  Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity.

Authors:  J A Fernández-Higuero; A Etxebarria; A Benito-Vicente; A C Alves; J L R Arrondo; H Ostolaza; M Bourbon; C Martin
Journal:  Sci Rep       Date:  2015-12-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.